HANGZHOU TIGERMED revenue breakdown overview

HANGZHOU TIGERMED revenue for the last year amounted to 6.60 B CNY, the most of which — 3.30 B CNY — came from its highest performing source at the moment, Clinical Trial Related Services and Laboratory Services, the year earlier bringing 3.12 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought HANGZHOU TIGERMED 3.55 B CNY, and the year before that — 4.23 B CNY.